Atlas Trials

RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer

Clinical trial NCT00629525 · COMPLETED

Trial details

NCT number
NCT00629525
Sponsor
Daniel George, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hormone Refractory Prostate Cancer
Start date
2005-08-01
Primary completion
2009-12-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.